107 related articles for article (PubMed ID: 17682609)
1. [Five years retrospective study of latanoprost glaucoma treatment].
Závorková M; Susický P
Cesk Slov Oftalmol; 2007 Jul; 63(4):292-8. PubMed ID: 17682609
[TBL] [Abstract][Full Text] [Related]
2. Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma.
Aspberg J; Heijl A; Jóhannesson G; Lindén C; Andersson-Geimer S; Bengtsson B
J Glaucoma; 2018 Nov; 27(11):976-980. PubMed ID: 30113517
[TBL] [Abstract][Full Text] [Related]
3. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
Br J Ophthalmol; 2007 Jun; 91(6):757-60. PubMed ID: 17124241
[TBL] [Abstract][Full Text] [Related]
4. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
5. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
6. Long term effect of latanoprost on intraocular pressure in normal tension glaucoma.
Ang A; Reddy MA; Shepstone L; Broadway DC
Br J Ophthalmol; 2004 May; 88(5):630-4. PubMed ID: 15090413
[TBL] [Abstract][Full Text] [Related]
7. Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.
Berthold S; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1029-34. PubMed ID: 16341541
[TBL] [Abstract][Full Text] [Related]
8. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
Mansouri K; Orguel S; Mermoud A; Haefliger I; Flammer J; Ravinet E; Shaarawy T
Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of latanoprost additive therapy on uncontrolled glaucoma.
Bayer A; Tas A; Sobaci G; Henderer JD
Ophthalmologica; 2002; 216(6):443-8. PubMed ID: 12566890
[TBL] [Abstract][Full Text] [Related]
10. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
13. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of latanoprost monotherapy treatment in primary open-angle glaucoma].
Martínez García A; Pérez García R
Arch Soc Esp Oftalmol; 2002 May; 77(5):269-74. PubMed ID: 12023746
[TBL] [Abstract][Full Text] [Related]
15. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
Hatanaka M; Reis A; Sano ME; Susanna R
J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
[TBL] [Abstract][Full Text] [Related]
16. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.
García-Sánchez J; Rouland JF; Spiegel D; Pajic B; Cunliffe I; Traverso C; Landry J
Br J Ophthalmol; 2004 Jul; 88(7):877-83. PubMed ID: 15205229
[TBL] [Abstract][Full Text] [Related]
18. The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.
Oh JY; Park KH
Korean J Ophthalmol; 2005 Dec; 19(4):297-301. PubMed ID: 16491821
[TBL] [Abstract][Full Text] [Related]
19. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC;
J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807
[TBL] [Abstract][Full Text] [Related]
20. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]